Advertisement
Screener

Starling Oncology, Inc. (STLN) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

Starling Oncology, Inc. Stock-Based Compensation

Starling Oncology, Inc. (STLN) reported Stock-Based Compensation of $2.76 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-06

  • Starling Oncology, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $1.07M, a 42.29% increase year-over-year.
  • Starling Oncology, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.69M, a 15.64% increase year-over-year.
  • Starling Oncology, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.32M, a 2.17% increase year-over-year.
  • Starling Oncology, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.02M, a 57.14% decline year-over-year.
  • Starling Oncology, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $4.55M, a 59.19% decline from fiscal 2024.
  • Starling Oncology, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $11.15M, a 37.38% decline from fiscal 2023.
  • Starling Oncology, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $17.81M, a 35.66% decline from fiscal 2022.
  • Starling Oncology, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $27.68M, a 12.83% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2026-06-30$1.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$2.76M
10-Q · filed 2026-08-06
$4.07M
derived: sum of 3 quarters · filed 2026-08-06
$5.10M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$1.69M
10-Q · filed 2026-05-07
$3.00M
derived: sum of 2 quarters · filed 2026-05-07
$4.03M
derived: sum of 3 quarters · filed 2026-05-07
$4.78M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$1.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$2.34M
derived: sum of 2 quarters · filed 2026-03-12
$3.09M
derived: sum of 3 quarters · filed 2026-08-06
$4.55M
10-K · filed 2026-03-12
2025-09-30$1.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$1.78M
derived: sum of 2 quarters · filed 2026-08-06
$3.23M
10-Q · filed 2025-11-13
$4.52M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$752.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$2.21M
10-Q · filed 2026-08-06
$3.50M
derived: sum of 3 quarters · filed 2026-08-06
$5.89M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$1.46M
10-Q · filed 2026-05-07
$2.75M
derived: sum of 2 quarters · filed 2026-05-07
$5.14M
derived: sum of 3 quarters · filed 2026-05-07
$8.52M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$1.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$3.68M
derived: sum of 2 quarters · filed 2026-03-12
$7.07M
derived: sum of 3 quarters · filed 2026-03-12
$11.15M
10-K · filed 2026-03-12
2024-09-30$2.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$5.78M
derived: sum of 2 quarters · filed 2025-11-13
$9.86M
10-Q · filed 2025-11-13
$13.94M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$3.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
$7.47M
10-Q · filed 2025-08-13
$11.55M
derived: sum of 3 quarters · filed 2025-08-13
$16.21M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31$4.09M
10-Q · filed 2025-05-14
$8.17M
derived: sum of 2 quarters · filed 2025-05-14
$12.82M
derived: sum of 3 quarters · filed 2025-05-14
$16.93M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$4.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26
$8.74M
derived: sum of 2 quarters · filed 2025-03-26
$12.85M
derived: sum of 3 quarters · filed 2025-03-26
$17.81M
10-K · filed 2025-03-26
2023-09-30$4.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
$8.77M
derived: sum of 2 quarters · filed 2024-11-13
$13.73M
10-Q · filed 2024-11-13
$19.80M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30$4.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
$9.07M
10-Q · filed 2024-08-13
$15.14M
derived: sum of 3 quarters · filed 2024-08-13
$21.69M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$4.96M
10-Q · filed 2024-05-14
$11.04M
derived: sum of 2 quarters · filed 2024-05-14
$17.58M
derived: sum of 3 quarters · filed 2024-05-14
$24.09M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$6.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$12.62M
derived: sum of 2 quarters · filed 2024-03-28
$19.13M
derived: sum of 3 quarters · filed 2024-03-28
$27.68M
10-K · filed 2024-03-28
2022-09-30$6.55M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$13.06M
derived: sum of 2 quarters · filed 2023-11-08
$21.61M
10-Q · filed 2023-11-08
$46.00M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30$6.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$15.07M
10-Q · filed 2023-08-09
$39.45M
derived: sum of 3 quarters · filed 2023-08-09
$39.51M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$8.55M
10-Q · filed 2023-05-10
$32.94M
derived: sum of 2 quarters · filed 2023-05-10
$32.99M
derived: sum of 3 quarters · filed 2023-05-10
$33.05M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$24.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$24.44M
derived: sum of 2 quarters · filed 2023-03-16
$24.49M
derived: sum of 3 quarters · filed 2023-03-16
$24.54M
10-K · filed 2023-03-16
2021-09-30$59.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$110.00K
derived: sum of 2 quarters · filed 2022-11-09
$152.00K
10-Q · filed 2022-11-09
2021-06-30$51.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$93.00K
10-Q · filed 2022-08-09
2021-03-31$42.00K
10-Q · filed 2022-05-10
2020-12-31$151.00K
10-K · filed 2022-03-11